UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| | | |
| Date of Report (Date of Earliest Event Reported): | | July 1, 2009 |
Charles River Laboratories International, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| | | |
| Delaware | 001-15943 | 06-1397316 |
_____________________
(State or other jurisdiction | _____________
(Commission | ______________
(I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| | | |
| 251 Ballardvale St., Wilmington, Massachusetts | | 01887 |
_________________________________
(Address of principal executive offices) | | ___________
(Zip Code) |
| | | |
| Registrant’s telephone number, including area code: | | 978-658-6000 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 1, 2009, Charles River Laboratories International, Inc. ("Charles River") announced that Real H. Renaud, Corporate Executive Vice President and President, Global Research Models and Services, had announced his intention to retire by the end of 2010. As a first step in a planned twelve to eighteen month transition of Mr. Renaud’s responsibilities, Charles River also announced the promotion of Davide Molho, D.V.M., to Corporate Senior Vice President, North American & European Research Models and Services. In his new role, Dr. Molho will assume responsibility for North American Research Models and Services (RMS), in addition to his leadership of the European RMS business.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | Charles River Laboratories International, Inc. |
| | | | | |
| July 2, 2009 | | By: | | Matthew L. Daniel
|
| | | | |
|
| | | | | Name: Matthew L. Daniel |
| | | | | Title: Sr. Corp. Counsel and Assistant Secretary |
